| - GRCh37:
- Chr10:43609948
- GRCh38:
- Chr10:43114500
| RET | C634R, C380R, C239R, C295R, C304R, C392R, C502R, C459R, C292R, C335R, C488R, C538R, C151R, C199R, C591R | Thyroid gland carcinoma, Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, not provided, Multiple endocrine neoplasia, type 2a | Pathogenic (May 21, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43609948
- Chr10:43609945
- Chr10:43609944
- GRCh38:
- Chr10:43114500
- Chr10:43114497
- Chr10:43114496
| RET, RET, RET | C634R, C380R, C239R, C295R, C304R, C392R, C502R, C459R, C292R, C335R, C488R, C538R, C151R, C199R, C591R, L379V, L633V, L590V, L150V, L198V, L238V, L391V, L458V, L291V, L303V, L334V, L487V, L537V, L294V, L501V, E378D, E632D, E149D, E197D, E302D, E486D, E500D, E237D, E290D, E293D, E536D, E589D, E333D, E390D, E457D | Multiple endocrine neoplasia, type 2a | Pathogenic (Jan 1, 1994) | no assertion criteria provided |